α-Synuclein in Parkinson's Disease

被引:883
|
作者
Stefanis, Leonidas [1 ,2 ]
机构
[1] Acad Athens, Biomed Res Fdn, Lab Neurodegenerat Dis, Athens 11527, Greece
[2] Univ Athens, Sch Med, Dept Neurol 2, GR-11527 Athens, Greece
来源
关键词
CHAPERONE-MEDIATED AUTOPHAGY; DOPAMINERGIC NEURONAL LOSS; NIGRA PARS COMPACTA; BETA-SYNUCLEIN; WILD-TYPE; DROSOPHILA MODEL; LEWY BODIES; IN-VIVO; INCLUSION FORMATION; MOUSE MODEL;
D O I
10.1101/cshperspect.a009399
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
alpha-Synuclein is a presynaptic neuronal protein that is linked genetically and neuropathologically to Parkinson's disease (PD). alpha-Synuclein may contribute to PD pathogenesis in a number of ways, but it is generally thought that its aberrant soluble oligomeric conformations, termed protofibrils, are the toxic species that mediate disruption of cellular homeostasis and neuronal death, through effects on various intracellular targets, including synaptic function. Furthermore, secreted alpha-synuclein may exert deleterious effects on neighboring cells, including seeding of aggregation, thus possibly contributing to disease propagation. Although the extent to which alpha-synuclein is involved in all cases of PD is not clear, targeting the toxic functions conferred by this protein when it is dysregulated may lead to novel therapeutic strategies not only in PD, but also in other neurodegenerative conditions, termed synucleinopathies.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] α-Synuclein and Parkinson's disease
    Burke, RE
    [J]. BRAIN RESEARCH BULLETIN, 1999, 50 (5-6) : 465 - 466
  • [2] α-synuclein and Parkinson's disease
    Iwatsubo, T
    [J]. SEIKAGAKU, 2002, 74 (06): : 477 - 482
  • [3] α-synuclein and Parkinson's Disease
    Recchia, A
    Debetto, P
    Negro, A
    Guidolin, D
    Skaper, SD
    Giusti, P
    [J]. FASEB JOURNAL, 2004, 18 (06): : 617 - 626
  • [4] α-synuclein and Parkinson's disease
    Golbe, LI
    [J]. PARKINSON'S DISEASE, 2003, 91 : 165 - 174
  • [5] β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson's Disease
    Xian, Meiyan
    Li, Jingwen
    Liu, Tingting
    Hou, Kaiying
    Sun, Lin
    Wei, Jianshe
    [J]. ACS CHEMICAL NEUROSCIENCE, 2024, 15 (13): : 2445 - 2453
  • [6] Neuropathology of α-synuclein in Parkinson's disease
    Choong, Chi-Jing
    Mochizuki, Hideki
    [J]. NEUROPATHOLOGY, 2022, 42 (02) : 93 - 103
  • [7] α-Synuclein misfolding and Parkinson's disease
    Breydo, Leonid
    Wu, Jessica W.
    Uversky, Vladimir N.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (02): : 261 - 285
  • [8] Aβ and α-synuclein pathologies in Parkinson's disease
    Lashley, T.
    Holton, J. L.
    Gray, E.
    Kirkham, K.
    Dunn, L.
    Wood, N.
    Lees, A. J.
    Revesz, T.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (02) : 256 - 256
  • [9] Agrochemicals, α-Synuclein, and Parkinson’s Disease
    Blanca A. Silva
    Leonid Breydo
    Anthony L. Fink
    Vladimir N. Uversky
    [J]. Molecular Neurobiology, 2013, 47 : 598 - 612
  • [10] Gangliosides, α-Synuclein, and Parkinson's Disease
    Ledeen, Robert W.
    Wu, Gusheng
    [J]. GANGLIOSIDES IN HEALTH AND DISEASE, 2018, 156 : 435 - 454